Sunday, 24 November 2024

Latest CDC Data: Cancer Cases Skyrocketed 14 Weeks Post-Vaccine Rollout—and the Surge Continues


The latest data obtained from the US Centers For Disease Control and Prevention (CDC) reveals that cancer cases began to surge 14 weeks after the COVID-19 mRNA vaccine rollout — and the cases have continued growing year-on-year to this day.

Cancer cases and deaths are climbing across all age groups, and treatment costs are spiraling—yet the government and mainstream media appear to be downplaying this silent crisis, even as the data tells a different story.

Recent data from the CDC and US Bureau of Labor Statistics combine to highlight significant increases in unexpected cancer-related deaths and new diagnoses, particularly among younger populations, raising questions and concerns about the long-term consequences of the mRNA rollout in early 2021.

According to the latest US data, unexpected cancer-related deaths are now 7.8% higher than forecast in 2024, as the year-on-year increases continue growing exponentially.

Source: Centers For Disease Control and Prevention (CDC)

Meanwhile, the annual growth rate for new cancer diagnoses has climbed to 2.3% — ten times higher than in previous years. This growth rate is unprecedented and signals a rapid increase in cancer’s impact across the US population.

These statistics suggest that new factors could be contributing to this rise, warranting thorough investigation and public health intervention to identify root causes and solutions.

Yet instead of launching a transparent public health intervention, the government, mainstream media, and Big Pharma seem more focused on obscuring the facts and manipulating data—avoiding difficult truths that vaccinated individuals should be told.

Source: US Bureau of Labor Statistics and US National Cancer Institute

As cancer cases increase, so do the associated costs for treatment. Adjusted for inflation, treatment costs have risen by 19%, creating an economic strain on healthcare systems and patients alike.

With cancer treatments already financially burdensome for many, this sharp increase in costs adds an extra layer of complexity to the crisis, impacting access to life-saving treatments.

The only people happy with this situation are the folks at Pfizer who made a $43 billion bet that turbo cancers would explode around the world in 2024. Seems like they had insider information.

Source: Centers For Disease Control and Prevention (CDC)

Notably, the spike in cancer rates isn’t just affecting older individuals. Those aged 0-54 have experienced a 30.9% increase in cancer cases, a concerning trend that contradicts the traditional view of cancer as primarily an illness of the elderly.

This shift toward younger demographics requires further research into potential environmental, lifestyle, or other factors including mRNA vaccination that could be contributing to increased cancer risks for younger people.

Source: US Bureau of Labor Statistics

The data clearly shows the surge in cancer cases and related treatments began around the 14th week of 2021, marking an inflection point.

This timing aligns with the COVID-19 vaccine rollout, and understanding the timeline is crucial for researchers as they seek to identify the contributing factors.

How long until society is mature enough to sit down and have frank and honest discussion about the disastrous consequences of the COVID-19 mRNA vaccine rollout?


Source link